Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2022 Dec 28;41:361. doi: 10.1186/s13046-022-02580-2

Retraction Note: miR-3928v is induced by HBx via NF-κB/ EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3

Qiaoge Zhang 1,#, Ge Song 1,#, Lili Yao 1, Yankun Liu 1,2, Min Liu 1, Shengping Li 3, Hua Tang 1,✉,#
PMCID: PMC9795646  PMID: 36575461

Retraction Note: J Exp Clin Cancer Res 37, 14 (2018)

https://doi.org/10.1186/s13046-018-0681-y

The Editor in Chief has retracted this article. After publication, concerns were raised about Figs. 4d, 5e, and 6h. These were addressed in a Correction [1]. Later, a new concern arose around the similarity between two GADPH blots in Fig. 2f. The authors provided raw images, which raised further concerns regarding MMP2 blots. Additionally, concerns have been raised regarding the ethics approval documentation provided by the authors. The Editor in Chief, therefore, has lost confidence in the findings of the paper. All authors agree to this retraction.

Footnotes

Qiaoge Zhang, Ge Song and Hua Tang contributed equally to this work.

Reference

  • 1.Zhang Q, Song G, Yao L, et al. Correction to: miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res. 2020;39:165. doi: 10.1186/s13046-020-01655-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES